本页面由Tiger Trade Technology Pte. Ltd.提供服务

Axsome Therapeutics, Inc.

184.30
+1.080.59%
盘后184.300.00000.00%19:47 EST
成交量:46.83万
成交额:8,628.16万
市值:92.91亿
市盈率:-39.52
高:185.51
开:183.09
低:182.71
收:183.22
52周最高:191.50
52周最低:86.99
股本:5,041.26万
流通股本:4,187.28万
量比:0.69
换手率:1.12%
股息:- -
股息率:- -
每股收益(TTM):-4.6630
每股收益(LYR):-5.9944
净资产收益率:-275.50%
总资产收益率:-19.79%
市净率:126.02
市盈率(LYR):-30.75

数据加载中...

2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/31

重要事件披露

Form 8-K - Current report
2025/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/03

重要事件披露

Form 8-K - Current report
2025/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities